Could AI-powered drugs save time, money and lives? – The National

Could AI-powered drugs save time, money and lives? – The National

Developing drugs is expensive, with a report this year from the business consultancy Deloitte estimating that major pharmaceutical companies invest, on average, $2.3 billion in each new medicine.

As well as being costly, drug development and testing, including several clinical trial stages, can take a long time, often more than a decade.

Artificial intelligence is creating a stir in the pharmaceutical industry through its potential to find new potential cures for illnesses and to streamline drug development.